Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03526536 · ClinicalTrials.gov registry record · Phase 4
Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD
A Phase 4 study, sponsored by State University of New York - Downstate Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT03526536 is a Phase 4 study that was terminated before completion, run by State University of New York - Downstate Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT03526536, a Phase 4 study, was terminated before completion, sponsored by State University of New York - Downstate Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is for people with diabetes who have either healthy kidneys or who have end stage renal disease (ESRD) and are on hemodialysis that are having surgery. This research will help increase our knowledge about how having diseased kidneys and being on hemodialysis changes how the body responds to insulin. In the time period directly before, during, and after surgery, maintenance of blood sugar within normal physiological range is essential. When patients come for surgery and have an elevated blood sugar, it is up to each individual physician to decide on the right amount of insulin to treat them. Currently, there are many different protocols across the country to treat elevated blood sugar; however, there is no one specific protocol to treat elevated blood sugar at SUNY Downstate Medical Center at this time. In this study, the investigators will evaluate the change in blood sugar following insulin administration to determine whether there is a significantly different response between ESRD and non-ESRD patients. The results of the study will help develop safer practice guidelines to patients with ESRD with an elevated blood sugar while they are having surgery.
Interventions
- DRUG IV Novolin R human insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-09-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03526536
The ClinicalTrials.gov registry entry for NCT03526536 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Downstate Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IV Novolin R human insulin is the first listed.
NCT03526536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03526536 about?
NCT03526536 is a clinical study titled "Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD". This study is for people with diabetes who have either healthy kidneys or who have end stage renal disease (ESRD) and are on hemodialysis that are having surgery. This research will help increase our knowledge about how having diseased kidneys and being on hemodialysis changes how the body responds ...
What is the current status of trial NCT03526536?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2018-05-01. Estimated completion is 2020-09-03.
What interventions are being tested in trial NCT03526536?
The interventions under investigation include: IV Novolin R human insulin (DRUG).
Who is sponsoring clinical trial NCT03526536?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.